Literature DB >> 19564760

Lumbar metastasis of choriocarcinoma.

Yohei Naito1, Koji Akeda, Yuichi Kasai, Akihiko Matsumine, Tsutomu Tabata, Kenji Nagao, Atsumasa Uchida.   

Abstract

STUDY
DESIGN: A case of lumbar metastasis of a choriocarcinoma is presented.
OBJECTIVE: To present and review a rare case of metastatic choriocarcinoma in the lumbar spine. SUMMARY OF BACKGROUND DATA: Choriocarcinoma is a highly anaplastic malignancy derived from trophoblastic cells characterized by the secretion of human chorionic gonadotropin (hCG) and early hematogenous metastasis. However, metastatic choriocarcinoma in the spine is extremely rare. Although 2 cases of metastasis in lumbar and/or sacral vertebra have been reported, the efficacy of surgical treatment for the spinal metastasis of choriocarcinoma is not yet known.
METHODS: The clinical course, radiologic features, pathology, and outcome of the treatment of metastatic choriocarcinoma of the lumbar spine is reported.
RESULTS: A 38-year-old female patient with abnormal uterine bleeding 6 weeks after a normal-term delivery showed high serum levels of hCG. A whole body image analysis revealed a lesion in the L2 vertebra. After computed tomography-guided needle biopsy, a clinical and pathologic diagnosis of lumbar metastasis of choriocarcinoma was made. Surgical resection of the localized L2 vertebra lesion was performed by total en bloc spondylectomy after a poor response to initial chemotherapy with methotrexate. Postsurgically, the serum level of hCG explosively increased and local recurrences around the original L2 vertebra and epidural metastasis abruptly developed. Lung metastases also occurred concurrently and progressed and the patient eventually died to the disease.
CONCLUSION: We have reported a rare case of lumbar metastasis of choriocarcinoma after a normal-term pregnancy. This is the first report of lumbar metastasis of choriocarcinoma treated by spinal surgery. Because surgical resection of a lumbar metastasis of choriocarcinoma involves a substantial risk of profuse hemorrhage, local recurrence and the spread of metastasis, multiagent chemotherapy in combination with radiotherapy should be preformed before surgical resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564760     DOI: 10.1097/BRS.0b013e3181a98746

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

1.  A case of lumbar metastasis of choriocarcinoma masquerading as an extraosseous extension of vertebral hemangioma.

Authors:  Ji Hoon Lee; Chan Woo Park; Dong Hae Chung; Woo Kyung Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-02-28

2.  Intramedullary spinal cord metastasis of choriocarcinoma.

Authors:  Jun Kyeung Ko; Seung Heon Cha; Jung Hwan Lee; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2012-03-31

3.  Choriocarcinoma presenting as an isolated bone marrow metastasis-a case report.

Authors:  Sarika Singh; Manjula Sardhana; Suneeta Sharma; Prakash Chitralkar
Journal:  Ecancermedicalscience       Date:  2014-01-29

4.  Metastatic choriocarcinoma to the lumbar spine: Case report and review of literature.

Authors:  Jesse Skoch; Kelly Kobylanski; Jeffrey M Rice; Ali A Baaj
Journal:  Surg Neurol Int       Date:  2014-11-21

Review 5.  En Bloc Resection of Solitary Functional Secreting Spinal Metastasis.

Authors:  C Rory Goodwin; Michelle J Clarke; Ziya L Gokaslan; Charles Fisher; Ilya Laufer; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-07-16

6.  Complications analysis of posterior vertebral column resection in 40 patients with spinal tumors.

Authors:  Yu Fan; Yu Xia; Hong Zhao; Jianguo Zhang; Shugang Li; Ye Tian; Xisheng Weng; Guixing Qiu
Journal:  Exp Ther Med       Date:  2014-08-22       Impact factor: 2.447

7.  Multidisciplinary treatment of life-threatening hemoptysis and paraplegia of choriocarcinoma with pulmonary, hepatic and spinal metastases: A case report.

Authors:  Yuan-Yuan Lin; Yang Sun; Yu Jiang; Bao-Zhi Song; Li-Juan Ke
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.